Rats, Mutant Strains < Rats, Sprague-Dawley < Rats, Wistar

Facettes :

List of bibliographic references

Number of relevant bibliographic references: 29.
[0-20] [0 - 20][0 - 29][20-28][20-40]

Ident.	Authors (with country if any)	Title
000205 (2000)	W G Ondo [États-Unis] ; Y. He ; S. Rajasekaran ; W D Le	Clinical correlates of 6-hydroxydopamine injections into A11 dopaminergic neurons in rats: a possible model for restless legs syndrome.
000258 (2000)	D D Truong [États-Unis] ; A. Kanthasamy ; B. Nguyen ; R. Matsumoto ; P. Schwartz	Animal models of posthypoxic myoclonus: I. Development and validation.
000259 (2000)	A G Kanthasamy [États-Unis] ; B Q Nguyen ; D D Truong	Animal model of posthypoxic myoclonus: II. Neurochemical, pathologic, and pharmacologic characterization.
000328 (2000)	M. Rodríguez [Espagne] ; P. Abdala ; J A Obeso	Excitatory responses in the 'direct' striatonigral pathway: effect of nigrostriatal lesion.
000499 (2001)	K P Datla [Royaume-Uni] ; S B Blunt ; D T Dexter	Chronic L-DOPA administration is not toxic to the remaining dopaminergic nigrostriatal neurons, but instead may promote their functional recovery, in rats with partial 6-OHDA or FeCl(3) nigrostriatal lesions.
000619 (2001)	O K Hassani [France] ; M. Mouroux ; G A Bohme ; J M Stutzmann ; J. Féger	Riluzole reduces hyperactivity of subthalamic neurons induced by unilateral 6-OHDA lesion in the rat brain.
000661 (2002)	Zaodung Ling [États-Unis] ; Dave A. Gayle ; Shang Yong Ma ; Jack W. Lipton ; Chong Wai Tong ; Jau-Shyong Hong ; Paul M. Carvey	In utero bacterial endotoxin exposure causes loss of tyrosine hydroxylase neurons in the postnatal rat midbrain.
000784 (2002)	Joanne E. Nash [Royaume-Uni] ; Jonathan M. Brotchie	Characterisation of striatal NMDA receptors involved in the generation of parkinsonian symptoms: intrastriatal microinjection studies in the 6-OHDA-lesioned rat.
000926 (2002)	Marie-Paule Muriel [France] ; Gaël Orieux ; Etienne C. Hirsch	Levodopa but not ropinirole induces an internalization of D1 dopamine receptors in parkinsonian rats.
000993 (2003)	Gregorio Segovia [Royaume-Uni] ; Francisco Mora ; Alan R. Crossman ; Jonathan M. Brotchie	Effects of CB1 cannabinoid receptor modulating compounds on the hyperkinesia induced by high-dose levodopa in the reserpine-treated rat model of Parkinson's disease.
000A12 (2003)	Manuel Rodríguez Díaz [Espagne] ; Pedro Barroso-Chinea ; Abraham Acevedo ; Tomás González-Hernández	Effects of dopaminergic cell degeneration on electrophysiological characteristics and GAD65/GAD67 expression in the substantia nigra: different action on GABA cell subpopulations.
000F29 (2004)	Tomás González-Hernández [Espagne] ; Pedro Barroso-Chinea ; Manuel Rodríguez	Response of the GABAergic and dopaminergic mesostriatal projections to the lesion of the contralateral dopaminergic mesostriatal pathway in the rat.
001103 (2005)	Fredricka C. Martin [États-Unis] ; Anh Thu Le ; Adrian Handforth	Harmaline-induced tremor as a potential preclinical screening method for essential tremor medications.
001549 (2006)	Concepci Marin [Espagne] ; Esther Aguilar ; José A. Obeso	Coadministration of entacapone with levodopa attenuates the severity of dyskinesias in hemiparkinsonian rats.
001948 (2007)	Penelope J. Hallett [États-Unis] ; J M Brotchie	Striatal delta opioid receptor binding in experimental models of Parkinson's disease and dyskinesia.
001A42 (2007)	Vincent Paillé [France] ; Vincent Henry ; Laurent Lescaudron ; Philippe Brachet ; Philippe Damier	Rat model of Parkinson's disease with bilateral motor abnormalities, reversible with levodopa, and dyskinesias.
002180 (2008)	Marios Hadjivassiliou [Royaume-Uni] ; Sabrina Boscolo ; Enrico Tongiorgi ; Richard A. Grünewald ; Basil Sharrack ; David S. Sanders ; Nicola Woodroofe ; G Aelwyn B. Davies-Jones	Cerebellar ataxia as a possible organ-specific autoimmune disease.
002C35 (2010)	Matteo Marti [Italie] ; Silvio Sarubbo ; Francesco Latini ; Michele Cavallo ; Roberto Eleopra ; Sara Biguzzi ; Christian Lettieri ; Carlo Conti ; Michele Simonato ; Silvia Zucchini ; Rocco Quatrale ; Mariachiara Sensi ; Sanzio Candeletti ; Patrizia Romualdi ; Michele Morari	Brain interstitial nociceptin/orphanin FQ levels are elevated in Parkinson's disease.
003289 (2011)	Elisa Garbayo [Espagne] ; Eduardo Ansorena ; Jose Luis Lanciego ; María Jose Blanco-Prieto ; María S. Aymerich	Long-term neuroprotection and neurorestoration by glial cell-derived neurotrophic factor microspheres for the treatment of Parkinson's disease.
003392 (2011)	Christopher Kobylecki [Royaume-Uni] ; Michael P. Hill ; Alan R. Crossman ; Paula Ravenscroft	Synergistic antidyskinetic effects of topiramate and amantadine in animal models of Parkinson's disease.
003988 (2013)	Erwan Bezard [France] ; Elisabetta Tronci ; Elsa Y. Pioli ; Qin Li ; Gregory Porras ; Anders Björklund ; Manolo Carta	Study of the antidyskinetic effect of eltoprazine in animal models of levodopa-induced dyskinesia.

---

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/Ncbi/Checkpoint

HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Checkpoint/Mesh.i -k "Rats, Sprague-Dawley" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Checkpoint/Mesh.i  \
                -Sk "Rats, Sprague-Dawley" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Ncbi/Checkpoint/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Santé
   |area=    MovDisordV3
   |flux=    Ncbi
   |étape=   Checkpoint
   |type=    indexItem
   |index=    Mesh.i
   |clé=    Rats, Sprague-Dawley
}}

---

This area was generated with Dilib version V0.6.23. Data generation: Sun Jul 3 12:29:32 2016. Site generation: Wed Feb 14 10:52:30 2024